Multivariate AnalysisPrognosisRetrospective StudiesRisk FactorsTreatment OutcomeSurvival AnalysisPrincipal Component AnalysisSurvival RateFollow-Up StudiesProspective StudiesPredictive Value of TestsProportional Hazards ModelsTime FactorsLogistic ModelsCohort StudiesNeoplasm StagingDisease-Free SurvivalKaplan-Meier EstimateAge FactorsTumor Markers, BiologicalCross-Sectional StudiesAnalysis of VarianceRegression AnalysisRisk AssessmentOdds RatioNeoplasm Recurrence, LocalCase-Control StudiesPrevalenceLymphatic MetastasisSex FactorsRecurrenceImmunohistochemistryIncidenceChi-Square DistributionQuestionnairesBreast NeoplasmsSeverity of Illness IndexDisease ProgressionUnited StatesBiological MarkersCombined Modality TherapySocioeconomic FactorsAntineoplastic Combined Chemotherapy ProtocolsLinear ModelsAdenocarcinomaLiver NeoplasmsROC CurvePostoperative ComplicationsLung NeoplasmsComorbidityNeoplasm InvasivenessJapanHIV InfectionsInfant, NewbornEpidemiologic MethodsSmokingRiskSensitivity and SpecificityFranceColorectal NeoplasmsDiscriminant AnalysisGenotypeLongitudinal StudiesChinaBody Mass IndexChemotherapy, AdjuvantCarcinoma, Squamous CellBrazilCarcinoma, HepatocellularItalyHospital MortalityTreatment FailureTissue Array AnalysisDemographyRegistriesProbabilityNeoplasm MetastasisStomach NeoplasmsConfidence IntervalsKi-67 AntigenModels, StatisticalReproducibility of ResultsAcute DiseaseNeoplasm GradingAge DistributionChronic DiseaseSpainMyocardial InfarctionPregnancyProstatic NeoplasmsStatistics as TopicCluster AnalysisCarcinoma, Non-Small-Cell LungCarcinomaRadiotherapy, AdjuvantEsophageal NeoplasmsRemission InductionAlgorithmsLength of StayGene Expression Regulation, Neoplastic